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Abstract: Objective: Low back pain is associated with
lumbar disc degeneration, which is mainly due to genetic
predisposition. The objective of this study was to perform
a systematic review to evaluate genetic association
studies in lumbar disc degeneration as defined on
magnetic resonance imaging (MRI) in humans.
Methods: A systematic literature search was conducted in
MEDLINE, MEDLINE In-Process, SCOPUS, ISI Web of
Science, The Genetic Association Database and The
Human Genome Epidemiology Network for information
published between 1990–2011 addressing genes and
lumbar disc degeneration. Two investigators indepen-
dently identified studies to determine inclusion, after
which they performed data extraction and analysis. The
level of cumulative genetic association evidence was
analyzed according to The HuGENet Working Group
guidelines.
Results: Fifty-two studies were included for review. Forty-
eight studies reported at least one positive association
between a genetic marker and lumbar disc degeneration.
The phenotype definition of lumbar disc degeneration
was highly variable between the studies and replications
were inconsistent. Most of the associations presented
with a weak level of evidence. The level of evidence was
moderate for ASPN (D-repeat), COL11A1 (rs1676486), GDF5
(rs143383), SKT (rs16924573), THBS2 (rs9406328) and
MMP9 (rs17576).
Conclusions: Based on this first extensive systematic
review on the topic, the credibility of reported genetic
associations is mostly weak. Clear definition of lumbar disc
degeneration phenotypes and large population-based
cohorts are needed. An international consortium is
needed to standardize genetic association studies in
relation to disc degeneration.
Introduction
Low back pain (LBP) is one of the world’s most debilitating
conditions, presenting with substantial socio-economic and
health-care consequences [1,2]. LBP can lead to reduced physical
activity, lost wages, diminished quality of life, and psychological
distress [3–6]. Although LBP has numerous determinants, disc
degeneration of the lumbar spine is a clear contributing factor
[7–13].
Disc degeneration is characterized as morphological and
biochemical changes of the disc. Magnetic resonance imaging
(MRI) is the current gold standard to assess the integrity of the
intervertebral disc [14]. Degenerative changes on imaging are
generally based on decreased signal intensity (representing loss of
hydration), reduced disc height, presence of fissures in the outer
layer of the disc or dislocation of disc material outside its normal
position [15–18]. Disc degeneration is multifaceted, traditionally
attributed to age, mechanical loading, gender, trauma, obesity and
other factors impairing disc nutrition [11,19–25]. However, since
the end of the 20th Century, numerous studies have suggested that
heredity is largely responsible for the development of lumbar disc
degeneration and that environmental factors play a much smaller
role than previously believed [26–28]. This has led to the well-
justified search for specific genetic risk factors [29]. However,
similar to other complex diseases, the genetic associations found in
disc degeneration have proven difficult to validate [30]. Only one
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limited attempt has been made to systematically analyze these
studies [31].
The current review is the first systematic assessment focusing
specifically on genetic association studies in disc degeneration
while including the evaluation of association credibility, which is
unique in this field. Published information of genetic factors is
growing rapidly and it needs to be approached systematically to
identify valid and replicable gene-disease associations [30,32].
Particularly in disc degeneration, in addition to summing up and
critically scrutinizing the existing data, such effort is needed for
planning future collaborative studies. As such, the primary
objectives of this study were to perform the first systematic
analysis of genetic association studies on lumbar disc degeneration,
evaluate the quality of the methods used in the studies, and assess
the level of evidence [33,34] in each association. Secondarily, the
objectives were to provide a basis on which the field could expand
towards more robust evidence and to assess the clinical relevance
of the current information. This review succeeded in reaching
these objectives.
Methods
Data Sources and Searches
A systematic search was conducted in MEDLINE, MEDLINE
In-Process, ISI Web Of Science and SCOPUS from 1990 through
to August 2011. On-line association databases, the Genetic
Association Database and the Human Genome Epidemiology
Network were consulted after a search for any missing studies. The
SCI-EXPANDED of ISI Web Of Science was searched from 1990
through to August 2011. Utilizing Boolean operators, different
forms (truncation) of the keywords allele, polymorphism and genotype in
either title or topic were combined with the words disc, disk,
endplate, lumbar, Modic, spondyl(o)arthrosis similarly in either title or
topic, and terms noting macular, retinal and ocular were used to
exclude conditions not related to the intervertebral disc. A search
in SCOPUS was performed in a parallel way using formulations of
the words allele, polymorphism and genotype in either title, abstract or
article keyword. This search was then combined with the words
disc, disk, endplate, lumbar, Modic and spondyl(o)arthrosis similarly in
either title, abstract or article keyword with AND Boolean. The
NOT operator was used with words macular, retinal, ocular and optic.
The MEDLINE and MEDLINE In-Process were searched using
the MeSH terms intervertebral disk degeneration and intervertebral disk
displacement prior to combining the word endplate and formulations
of spondyloarthrosis to the search in all fields -manner. Different
formulations of the words allele, polymorphism and genotype were then
combined with AND Boolean. Finally the results were limited to
humans. The Genetic Association Database (http://
geneticassociationdb.nih.gov/) was searched using the words disc
and disk in all fields-manner. The Human Genome Epidemiology
Network (HuGENetTM) was also searched via the HuGE
Literature Finder (http://hugenavigator.net/) using the words disc
and disk. Reference tracking of included studies was performed
after retrieving the full text articles. The citations were handled
using the RefWorks–software (ProQuest LLC, both Classic and
2.0 versions were used).
Study Selection
The criteria for considering studies for this review were
formalized in an inclusion criteria form (Appendix S1), which
was piloted to minimize human error. Two investigators (PE and
SL) independently examined the titles and abstracts of the
identified studies. If study eligibility was unclear from the abstract,
the full text of the article was retrieved and independently assessed
by the assessors (Figure 1). Any disagreement was resolved by
discussion. Eligible studies included in this review had the
following criteria: relevant outcome or disease (intervertebral disc
changes, vertebral endplate changes, spondyl(o)arthrosis), reliable
definition of outcome (MRI), study subjects not less than fifty,
human subjects, and description of specific genetic variant(s).
Studies that did not meet one or more of the eligibility criteria
were excluded. The studies were not limited to any language.
Data Extraction
Two investigators (PE and SL) independently extracted the data
using a standardized form (Appendix S1). The form was pilot-
tested on three studies to identify and reduce any potential for
misinterpretation (PE, SL and PK). The following topics were
recorded from the included studies: study details and sponsorship,
population structure, phenotypes and details of the MRI,
genotyping details as well as possible biases in selection,
performance, detection, attrition and statistical analyses.
Quality Assessment and Data Synthesis
We developed an instrument for methodological quality
assessment (Appendix S1). The study quality was based on the
information reported in the articles and was simultaneously
analyzed with the data extraction phase by two investigators (PE
and SL) independently. However, during the data analysis phase,
it was noted that the formalized summary score did not fully serve
all the needs of the current review [35]. This discrepancy was
resolved through discussion (PE and SL), after which the
synthesized study quality assessment was noted when estimating
protection from bias at the level of evidence analyses. The level of
evidence in each genetic variation was analyzed according to the
Venice interim guidelines by The HuGENet Working Group [33].
Figure 1. Study flow diagram.
doi:10.1371/journal.pone.0049995.g001
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These current guidelines suggest that the level of evidence for
genetic association should be assessed at three main levels: amount
of evidence, replication and protection from bias. The amount of
evidence was graded strong (A) in the case of .1000, moderate (B)
in the case of 100–1000 and weak (C) in the case of ,100
individuals evaluated in the smallest genetic group of interest. The
level of replication was graded strong (A): extensive replication
including at least one well-conducted meta-analysis with little
between-study inconsistency; moderate (B): well-conducted meta-
analysis with some methodological limitations or moderate
between-study inconsistency; and weak (C): no association, no
independent replication, failed replication, scattered studies,
flawed meta-analysis or large inconsistency. Similar tripartite
grading was used to analyze the protection from bias: strong (A):
bias, if at all present, could affect the magnitude but probably not
the presence of the association; moderate (B): no obvious bias that
may affect the presence of the association but there is considerable
missing information on the generation of evidence; and weak (C):
considerable potential for, or demonstrable, bias that can affect
even the presence or absence of the association [33,34]. For a
positive replication, both the same phenotype and the same
genetic variation were required. The possible additional biological
evidence reported in the studies was also acknowledged [33].
Credibility of cumulative epidemiological evidence was recorded
for each variation as described in the guidelines (Appendix S1).
Two investigators (PE and SL) confirmed the credibility assess-
ments, which were then further reviewed by the other investiga-
tors. We examined the studies and extracted data with close
scrutiny in order to identify possible multiple association reports
from a single study or clear double publications. Multiple
association reports from a single study or population were
included if they reported on different genetic variations or
different disc degeneration phenotypes than those contained in
the first report. Multiple association reports were not allowed to
inflate the level of association evidence.
Results
The systematic search resulted in 1,356 citations (Figure 1).
Duplications and clearly unrelated titles (N= 1240) were removed
and the full-text articles of the remaining titles were obtained.
Reference tracking, independent evaluation and reviewer discus-
sions found 52 studies eligible for inclusion (Table S1). The list of
studies that were excluded after evaluation (N= 72) can be found
on-line (Appendix S1). One double publication was identified
[36,37], and the more recent report was excluded.
Methods and Phenotypes in Studies
The genetic association studies identified in this review were
published from the year 1998 onwards. All 52 studies included in
this review used a candidate gene approach. The number of
studied polymorphisms in each study varied between one and 163
[38,39]. The accuracy of the study methodology and reporting
improved from the early to the more recent studies. However,
many items still related to error and bias were not consistently
reported. Genotyping methodology was generally found to be
suitable for each study performed, although methods to validate
genotyping, as well as blinding of genotyping towards phenotype
or vice versa, were rarely reported. In many cases, the phenotype of
disc degeneration varied between the initial and replication studies
(Table S1, Table 1) [36,38–84]. The phenotype of disc herniation
characterized by sciatica showed the most convincing evidence for
association as it was the phenotype in 80% of the studies with
moderate evidence of association in the current review (Table 2).
The other phenotypes used in the original studies included
decrease in disc signal intensity or disc height, disc bulges, disc
herniations without specification of symptoms, Modic changes,
osteophytes and lumbar spinal stenosis. Different modifications
and combinations of these were also used. Despite several studies
investigating the same genetic variation, meta-analysis was not
feasible due to the clinical and overall heterogeneity of the studies.
Additional biological evidence was reported in six studies
[50,52,69,78,85,86]. References for equivalent rs-numbers [87]
for the identified polymorphisms are available on-line as
supplementary data (Appendix S1).
Level of Association Evidence
None of the genetic variations reached the level of strong
evidence for association in the current review. We found a
moderate level of evidence for variations from studies investigating
asporin (ASPN), collagen XI alpha 1 (COL11A1), growth differentiation
factor 5 (GDF5), Sickle tail (SKT); thrombospondin 2 (THBS2) and matrix
metalloproteinase 9 (MMP9) genes (Table 2). These studies had at
least a moderate amount of evidence, replication in an indepen-
dent sample (same or independent report), meta-analysis or a
combined analysis performed in the initial study (Table 3),
sufficient protection from bias, and a high statistical significance
level in the initial study. Furthermore, additional biological
evidence was reported in the original papers for all these
polymorphisms (Table 2). Inadequacy in the number of subjects,
lack of an independent replication report or some inconsistency in
replications, phenotyping problems or missing information in the
report to evaluate protection from bias hindered these associations
from reaching the level of strong association evidence (Table 1,
Table 2, Table 3).
The association study of ASPN consisted of two independent
Asian cohorts of Japanese (N= 1353) and Chinese (N= 1055)
origin as reported by Song et al [50]. All Japanese cases had a
lumbar disc herniation characterized by sciatica (LDH) confirmed
by MRI, while disc signal decreases were also recorded.
Association between the presence of at least one D14 allele and
LDH was found to be significant, while in the Chinese population
the presence of at least one D14 repeat was associated with lumbar
disc degeneration. A meta-analysis using the above-mentioned
phenotypes showed that individuals carrying the D14 allele had
increased odds of LDH or disc degeneration 1.7-fold (Table 3)
[50].
A Japanese study found an association between COL11A1
rs1676486 T-allele and LDH characterized by sciatica. The
original study consisted of three case-control populations (N= 367,
N= 645, N=710), each independently showing a significant
association. When the populations were combined for meta-
analysis (N= 1661), the minor allele T was more prevalent among
cases compared to controls (Table 3). Additional biological
evidence was also reported [69].
A recent multicohort study with Northern European subjects
investigated the rs143383 of the GDF5 gene. Out of the total
population (N= 5259), one cohort (N= 613) was scanned with
MRI, therefore making the study eligible for our review. In the
meta-analysis rs143383, a significant association was found among
women for combined phenotype of disc space narrowing and
osteophytes (Table 3). When only the MRI cohort was investigat-
ed, the association was not statistically significant, thus generating
some inconsistency in this association [88]. However, as this
specific disc degeneration phenotype can be obtained on multiple
imaging modalities, such as radiographes, computed tomography
or MRI [89], we included the results of the meta-analysis.
Genetic Association Studies in Disc Degeneration
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Another recent study analyzed the Sickle tail (SKT) gene
polymorphisms [86]. Of the 68 SNPs studied, the rs16924573 was
the most strongly associated with LDH among Japanese subjects
(N= 1758) and the finding was replicated among Finnish subjects
(N= 506) (Table 3) [86]. Allele frequencies were different between
Finnish and Japanese populations, but the meta-analysis of over
2200 subjects supported the association (Table 3) [85]. A
replication study between disc signal decrease and SKT
rs16924573 has been recently published (OR 0.27 [95% CI
0.07–0.96], p = 0.024) [56]. The G-allele frequency was higher in
the case group of both studies, thus indicating an increased risk.
However, the A-allele was rarer in the more recent study and the
association was only seen when the GA-genotype was compared to
GG-genotype. Therefore the OR in the more recent study is
protective [56].
Two thrombospondin genes (thrombospondin-1 and THBS2)
were examined in two independent Japanese populations
(N= 1089 and N=654) as candidate genes for LDH. Multiple
polymorphisms of the THBS2 were associated with LDH. The
polymorphism rs9406328 showed significant association in both
populations independently as well as when populations were
combined (Table 3) [78]. The same study also reported a
Table 1. Initial and replication study phenotypesa.
Gene Variation Initial phenotype Replication study phenotypes
ACAN VNTR D N,D,H,B,S,U,St
rs1042631 D,B 2
ASPN Allele D14 S,D 2
CASP9 rs1052576 H(S) 2
CILP rs2073711 S D,S
COL1A1 rs2075555 D 2
COL9A1 rs696990 D,B 2
COL9A2 rs137853213 S S,D,E
COL9A3 rs61734651 S S,D,B,E,g
COL11A1 rs1676486 S 2
rs1463035 B 2
COL11A2 intron9 B 2
rs2076311 D 2
rs1799907 St D
FAS rs2234767 N 2
FASLG rs763110 N 2
GDF5 rs143383 X 2
IL1A rs1800587 B D,H,E,S
rs2071375 D 2
IL1B rs1143634 B D,E,H,g
IL1RN VNTR H(S) S
IL18RAP rs1420100 D 2
IL6 (rs1800795, rs1800796, rs1800796) S D
IL10 21082A/G D 2
2592A/C D 2
MMP1 21607 D 2
MMP2 21306C/T S 2
MMP3 21171 X St
MMP9 rs17576 S D
21562C/T S,N 2
NOS2 exon22 H 2
NOS3 2786T/C H 2
SKT rs16924573 S D
THBS2 rs9406328 S D
VDR FokI D St,U,D,H,E
TaqI D St,U,D,N,H,E
aDisc degeneration phenotype (D= disc signal changes using different classifications, S = disc herniation with sciatica, N = nonspecific discogenic pain with disc
degeneration, B = disc contour change; bulge, H =disc contour change; herniation without specified clinical symptoms, E = endplate changes including Modic changes,
U = unspecified degenerative phenotype, X = plain radiograph; MRI for some subjects, St = stenosis, disc signal decrease also recorded, g= combination phenotype).
doi:10.1371/journal.pone.0049995.t001
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significant association between the rs17576 of the MMP9 gene and
LDH (Table 3) [78].
In this review, the most studied candidate genes for LDD were
vitamin-D receptor (VDR), aggrecan (ACAN), interleukin-1 alpha (IL1A),
interleukin-1 beta (IL1B), collagen IX alpha 2 (COL9A2) and collagen IX
alpha 3 (COL9A3) (Table S1). However, a large proportion of the
association studies investigating disc degeneration had some faults,
which weakened the evidence for association. The most common
weaknesses were the relatively low number of study subjects and
difficulty in replicating the previous association signal. In general,
there was a lack of replication; and where replication did exist,
studies were often too heterogeneous, leading to inconsistencies
and differences in the final phenotype. In some studies, protection
from bias seemed to be insufficient. However, due to failure to
report the study details properly, it was often very difficult to
adequately assess studies. In summary, due to general heteroge-
neity of studies, replications were inconclusive and meta-analyses
were not feasible, thus leading to a weak level of association
evidence in many cases.
Protein–protein Interaction Network Analysis
We performed post hoc analysis (Appendix S1) for protein–
protein interactions (PPI) network combining all genes from
included studies with any positive association as input [90]. This
resulted in a significant (p,0.0001) network including 60.7% (17/
28) of the genes with positive associations reported in the included
studies, and proposed 76 new interaction partners as possible
topics of future investigations (Figure 2). The PPI results were not
incorporated into the credibility levels of previously identified
associations.
Discussion
The study of lumbar disc degeneration is clinically relevant.
Numerous studies have noted that lumbar disc degeneration is
associated with LBP [7–13,91]. Therefore, to determine preven-
tative and therapeutic measures for LBP, it is beneficial to
understand the etiology of disc degeneration. However, lumbar
disc degeneration is a multifaceted condition, in which hereditary
factors play an important role. Our knowledge about the natural
history of degenerative disc disease is constantly improving
[14,25]. Still, the complexity of the degenerative process is not
fully understood. For example, disc space narrowing, facet disease
and spinal stenosis tend to progress slowly over time while disc
herniations can occur rapidly [92–94]. Imaging techniques have
improved significantly [15] since the earliest genetic association
reports; however, the definitions of the imaging phenotype, subject
selection and study detail reporting are not consistent or
standardized in this field.
In this first extensive systematic review on the subject, we
identified 52 candidate gene studies that had used MRI for disc
degeneration definition and defined a specific genetic polymor-
phism. The phenotype with the most convincing evidence was disc
herniation characterized by sciatica. This phenotype was utilized
in 80% (ASPN, COL11A1, SKT, THBS2 and MMP9) of the studies
with a moderate level of evidence in the current review.
All the genes in which the variations were found to have a
moderate level of evidence are biologically plausible in disc
degeneration. The asporin protein, coded by ASPN, is one of the
small leucine-rich proteoglycans of the lumbar disc playing an
important role in cartilage homeostasis. The specific D14-allele,
that we found had a moderate level of evidence, has been reported
to decrease collagen type II and aggrecan synthesis via inhibition
of transforming growth factor beta 1 (TGF-b), which is a regulator
of cartilage metabolism [95]. Type XI collagen is a minor
component of the lumbar disc. It is expressed both in the outer
and inner parts of the disc, and it has an important function in the
interplay of collagens and proteoglycans [96]. The rs1676486 T-
allele has been reported to result in decreased synthesis and
stability of COL11A1 mRNA suggesting a functional importance in
disc degeneration [69]. The growth differentiation factor 5, coded
by GDF5, is a cartilage anabolic protein and has been linked with
both osteoarthritis and disc degeneration [88,97]. The rs143383,
which was associated with increased risk for disc degeneration, has
been reported to have genome-wide significance in multiple
musculoskeletal phenotypes such as height and Achilles tendino-
pathy. However, the modulation of GDF5 expression seems to be
intricate [98,99]. The human SKT is expressed in the human
intervertebral disc and the importance of this gene in disc
development has been established previously in an animal study
[100]. The specific way in which SKT participates in disc
homeostasis and the functional importance of the identified risk
variation rs16924573 remains to be elucidated [86]. Thrombos-
Table 2. Candidate genes with a moderate level of epidemiological evidence in lumbar disc degenerationa.
Gene Variation
Amount of
evidence
Replication
Level
Protection
From Bias
Additional
biological
evidenceb Ethnicity Phenotype Reference
ASPN allele D14 B B B yes Japanese
Chinese
sciatica and disc
signal
Song et al 2008
COL11A1 rs1676486 B B B yes Japanese sciatica Mio et al 2007
GDF5 rs143383 A B A 2 Northern
European
X-rayc, partially
MRI
Williams et al 2011
SKT rs16924573 B B A yes Japanese
Finnish
sciatica Karasugi et al 2009
THBS2d rs9406328 B B B yes Japanese sciatica Hirose et al 2008
MMP9d rs17576 B B B yes Japanese sciatica Hirose et al 2008
aBased on Venice interim guidelines [33], statistical significance level (p-value) of original association and replication level including also the absence of inconsistent
replications. Amount of evidence increases when alleles are contrasted.
bReported in the included studies.
cCombined phenotype of disc space narrowing and presence of osteophytes.
dOne negative replication report [54] in disc signal phenotype.
doi:10.1371/journal.pone.0049995.t002
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pondin-2 (THBS2), which is also expressed in the disc, regulates
the effective levels of catabolic proteins (matrix metalloproteinase-
2 and MMP9) in the extracellular matrix. The variation
rs9406328, with a moderate level of association evidence, has
been reported to have an effect on THBS2 binding with these
catabolic proteins. Furthermore, the variation rs17576 in MMP9 is
located within a highly conserved region and possibly has an effect
on substrate binding [78].
The earlier non-systematic reviews have suggested that various
other genes may be related to the development of lumbar disc
degeneration [29,101–107]. However, based on our systematic
review, there is only a weak level of evidence for these genes at the
most. This is probably due to more strict inclusion criteria applied
in the current review; for instance, studies without MRI
evaluation, as well as studies reporting success of surgical
treatments as the phenotype, have been included in some of the
earlier reviews. Moreover, studies with less than 100 subjects in the
smallest genetic group, no replication/meta-analysis or with some
bias were currently considered as having weak evidence.
Based on our systematic review, the quality of the evaluated
studies varied considerably and some recurrent weaknesses were
identified. Definitions of imaging phenotypes were not clearly
reported and there was some variability in the selection of subjects.
Further, there were a few studies where the control group was not
evaluated using MRI or subjects with LBP and/or sciatica were
included as controls. As such, differences in subject selection and
phenotype definition hindered efforts to produce a reasonable
meta-analysis. Population-based studies with large study samples
with adequate statistical power were rare; in fact, only five studies
possessed a sample size greater than 1000. Quality control steps,
such as population stratification, Hardy-Weinberg equilibrium
testing, and statistical power calculations, were often not
consistently reported, even though the reporting improved in
more recent publications [108]. Moreover, the publication bias
(i.e. the tendency to under-report negative results) was clearly
visible in the published data under review, whereby nearly 90% of
the included studies reported positive associations between lumbar
disc degeneration and specific polymorphisms.
Variation in allele frequencies between different ethnic popu-
lations (e.g. Caucasians, Asians) may suggest that different risk
alleles may be involved in the development of lumbar disc
degeneration in different ethnic groups. Thus, replication studies
are needed in study populations of similar and different ethnic/
geographic origin to provide a more comprehensive understand-
ing. In the current systematic review, the most consistent evidence
(i.e. moderate evidence) was based on studies in Asian populations.
However, in one study, the association with moderate evidence
(SKT gene and sciatica) was originally reported in Japanese and
replicated in Finnish population [56,86]. Alternatively, in many
cases, replications were inconsistent, either due to different
phenotypes or different genetic variation examined in the
replication study (Table 1).
In lumbar disc degeneration, possibilities to develop an even
larger number of distinct phenotypes expand as new imaging
techniques, such as high field T1r or T2 relaxation mapping, are
used more widely [109–112]. Although there have been recent
suggestions to adapt to differences in phenotypes [113], there is a
great risk that without standardization of subject selection (e.g.
population-based vs. patient-based), phenotype definition and
study detail reporting in this field, such an approach will further
contribute to the development of an even more complex state in
disseminating the evidence for the association between genetics
and lumbar disc degeneration. Afterall, the clinically relevant
endpoints of disc degeneration, pain or neurological deficits, are
similarly complex entities and it is unlikely that sound progress
would be achieved via incorporation of all the phenotypes.
Therefore, the cumulative epidemiological evidence described in
Figure 2. PPI-network analysis. Significant PPI-network (p-value ,0.0001) containing 17 proteins associated with disc degeneration (red circles)
and 76 interaction partners (white circles).
doi:10.1371/journal.pone.0049995.g002
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the current review can be considered ‘early evidence’, as defined
by The HuGENet Working Group [33].
Rapid advancements in genetics and bioinformatics have led to
the situation where the amount of data under analysis has
increased substantially [114–119], providing new opportunities to
reveal genetic background of complex traits. Over the last 5 years,
genome-wide association studies (GWAS) have become a powerful
tool for identifying common genetic variants, which have led to the
discovery of common risk loci for several complex diseases [120–
123]. However, to our knowledge, no GWAS has yet been
published to address lumbar disc degeneration. On the other
hand, the protein-protein interaction analyses, that we also
included, are currently considered to be a valuable method in
order to deepen our understanding of common complex diseases
[117,124,125]. These interactions between proteins demonstrate
one of the strongest functional relationships between genes.
Therefore, by combining the genomic data with available
proteomic data, we may gain a more in-depth understanding of
common human diseases [117]. The current protein-protein
interaction analysis included in this review can act as a starting
point to stimulate forthcoming research. For more refined
discovery of risk variants for several complex traits, efforts towards
incorporating exome or whole-genome sequencing approaches,
due to increased capacity and accuracy of next-generation
sequencing, are currently being carried out.
In conclusion, our systematic review has noted multiple genetic
polymorphisms to be related to the development of lumbar disc
degeneration; however, due to variation between study designs,
sampling methods, populations, and phenotype definitions, the
level of evidence of that association remains weak. As such, our
review stresses the limitations of the current status of genetic
association studies in relation to lumbar disc degeneration.
Collaborative studies with large population-based cohorts and
well-defined phenotypes as well as genotype characteristics are
necessary for major advances in understanding the genetic
component of lumbar disc degeneration. By increasing the
understanding of the etiology of lumbar disc degeneration,
preventative and therapeutic measures can be designed to address
such degenerative changes, which may also translate into
decreasing the risk of developing LBP and its consequences.
Therefore, a call to action to establish an international consortium
is needed to standardize methods and limit variations between
genetic studies of lumbar disc degeneration.
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